Muscle Atrophy Clinical Trials

Find Muscle Atrophy Clinical Trials Near You

Morphometric Characteristics of Internal Organs and Morphofunctional Status of the Musculoskeletal System in Patients With Hypothyroidism

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

HYPOMORPH is a hospital-based observational cross-sectional study designed to comprehensively characterise internal-organ morphometry and musculoskeletal status in adults with previously diagnosed hypothyroidism receiving routine medical care in Andijan, Uzbekistan. Approximately 500 adults aged 18-59 years will be included. Participants undergo standardised clinical and anthropometric assessment, ultrasonographic examination of the liver, pancreas and both kidneys, measurement of handgrip strength, and assessment of physical performance using the Five Times Sit-to-Stand Test and 4-m gait speed test. Sarcopenia risk and habitual physical activity are assessed using the SARC-F questionnaire and the International Physical Activity Questionnaire-Short Form (IPAQ-SF), respectively. Serum thyroid-stimulating hormone (TSH) and free thyroxine (FT4) concentrations are measured to characterise thyroid functional status at the time of assessment. The study evaluates ultrasonographic morphometric characteristics of the liver, pancreas and kidneys and musculoskeletal functional characteristics, and investigates their associations with thyroid-related, anthropometric, clinical and laboratory variables. Multivariable regression analyses will be used to identify factors independently associated with organ-specific morphometric and functional outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 59
Healthy Volunteers: f
View:

• Adults aged 18-59 years.

• Previously established diagnosis of hypothyroidism.

• Receiving routine outpatient or inpatient care at participating healthcare institutions.

• Ability to undergo ultrasonographic, anthropometric and functional assessments.

• Provision of written informed consent.

Locations
Other Locations
Uzbekistan
Andijan State Medical Institute
RECRUITING
Andijan
Contact Information
Primary
Abdukhalim Kh. Abdurakhimov, PhD
abduhalim@adti.uz
+998941010091
Time Frame
Start Date: 2026-06-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 500
Treatments
Patients With Hypothyroidism
Adults aged 18-59 years with a previously established diagnosis of hypothyroidism who are receiving routine outpatient or inpatient care at participating healthcare institutions in Andijan, Uzbekistan. Participants undergo standardised clinical and anthropometric assessment, ultrasonographic evaluation of the liver, pancreas and both kidneys, musculoskeletal functional assessment and laboratory testing according to the study protocol.
Related Therapeutic Areas
Sponsors
Leads: Andijan State Medical Institute

This content was sourced from clinicaltrials.gov